MENU
+Compare
MIRM
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$40.43
Change
+$0.81 (+2.04%)
Capitalization
1.95B

MIRM Mirum Pharmaceuticals Forecast, Technical & Fundamental Analysis

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more

MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MIRM with price predictions
Apr 23, 2025

MIRM's RSI Indicator climbs out of oversold territory

The RSI Oscillator for MIRM moved out of oversold territory on April 16, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 15 similar instances when the indicator left oversold territory. In of the 15 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where MIRM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on MIRM as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

MIRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MIRM turned negative on April 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

MIRM moved below its 50-day moving average on March 21, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MIRM entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.643) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (5.562) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MIRM is expected to report earnings to fall 83.28% to -30 cents per share on May 01

Mirum Pharmaceuticals MIRM Stock Earnings Reports
Q1'25
Est.
$-0.31
Q4'24
Missed
by $1.55
Q3'24
Beat
by $0.15
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.12
The last earnings report on February 26 showed earnings per share of -185 cents, missing the estimate of -30 cents. With 79.54K shares outstanding, the current market capitalization sits at 1.95B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZUOX14.95N/A
N/A
Lazard US Equity Focus Open
CLXRX54.92N/A
N/A
Columbia Large Cap Index Inst2
APDKX49.17N/A
N/A
Artisan International Value Advisor
FEQJX12.28N/A
N/A
Fidelity Advisor Hedged Equity Fund I
ERLGX17.35N/A
N/A
Eaton Vance Atlanta Capital Fcs Gr R6

MIRM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with GERN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+0.42%
GERN - MIRM
41%
Loosely correlated
-2.84%
FHTX - MIRM
37%
Loosely correlated
+10.38%
CYCC - MIRM
36%
Loosely correlated
+0.93%
RARE - MIRM
35%
Loosely correlated
+3.90%
ZNTL - MIRM
35%
Loosely correlated
+1.70%
More